Sökresultat - "peripheral blood"

A comparison of mobilization regimens used in Hodgkin lymphoma and factors that influence peripheral blood stem cell mobilization.

Gokarn A; Department of Medical Oncology, ACTREC, Tata Memorial Centre, Mumbai, India; Homi Bhabha National Institute, Mumbai, India., Reddy L; Department of Medical Oncology, ACTREC, Tata Memorial Centre, Mumbai, India., Hiregoudar S; Homi Bhabha National Institute, Mumbai, India; Department of Transfusion Medicine, ACTREC, Tata Memorial Centre, Mumbai, India., Poojary M; Homi Bhabha National Institute, Mumbai, India; Department of Transfusion Medicine, ACTREC, Tata Memorial Centre, Mumbai, India., Parab S; Department of Transfusion Medicine, ACTREC, Tata Memorial Centre, Mumbai, India., Punatar S; Department of Medical Oncology, ACTREC, Tata Memorial Centre, Mumbai, India; Homi Bhabha National Institute, Mumbai, India., Chichra A; Department of Medical Oncology, ACTREC, Tata Memorial Centre, Mumbai, India; Homi Bhabha National Institute, Mumbai, India., Mirgh S; Department of Medical Oncology, ACTREC, Tata Memorial Centre, Mumbai, India; Homi Bhabha National Institute, Mumbai, India., Jindal N; Department of Medical Oncology, ACTREC, Tata Memorial Centre, Mumbai, India; Homi Bhabha National Institute, Mumbai, India., Nayak L; Department of Medical Oncology, ACTREC, Tata Memorial Centre, Mumbai, India; Homi Bhabha National Institute, Mumbai, India., Garg K; Department of Medical Oncology, ACTREC, Tata Memorial Centre, Mumbai, India., Saha S; Homi Bhabha National Institute, Mumbai, India; Department of Transfusion Medicine, ACTREC, Tata Memorial Centre, Mumbai, India., Ojha S; Homi Bhabha National Institute, Mumbai, India; Department of Transfusion Medicine, ACTREC, Tata Memorial Centre, Mumbai, India., Tembhare P; Homi Bhabha National Institute, Mumbai, India; Hematopathology laboratory, ACTREC, Tata Memorial Centre, Mumbai, India., Rajpal S; Homi Bhabha National Institute, Mumbai, India; Hematopathology laboratory, ACTREC, Tata Memorial Centre, Mumbai, India., Chatterjee G; Homi Bhabha National Institute, Mumbai, India; Hematopathology laboratory, ACTREC, Tata Memorial Centre, Mumbai, India., Patkar N; Homi Bhabha National Institute, Mumbai, India; Hematopathology laboratory, ACTREC, Tata Memorial Centre, Mumbai, India., Kannan S; Department of bio-statistics, ACTREC, Tata Memorial Centre, Mumbai, India., Pawar A; Department of bio-statistics, ACTREC, Tata Memorial Centre, Mumbai, India., Bagal B; Department of Medical Oncology, ACTREC, Tata Memorial Centre, Mumbai, India; Homi Bhabha National Institute, Mumbai, India., Subramanian PG; Homi Bhabha National Institute, Mumbai, India; Hematopathology laboratory, ACTREC, Tata Memorial Centre, Mumbai, India., Khattry N; Department of Medical Oncology, ACTREC, Tata Memorial Centre, Mumbai, India; Homi Bhabha National Institute, Mumbai, India. Electronic address: nkhattry@gmail.com.

Journal Article; Comparative Study , 2025

Allogeneic transplantation of bone marrow versus peripheral blood stem cells from HLA-identical sibling donors for hematological malignancies in 6064 adults from 2003 to 2020: different impacts on survival according to time period.

Konuma T; Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan. Electronic address: tkonuma@ims.u-tokyo.ac.jp., Miyao K; Department of Hematology and Oncology, Anjo Kosei Hospital, Anjo, Japan., Nakasone H; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan., Ouchi F; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan., Fukuda T; Hematopoietic Stem Cell Transplantation Division, National Cancer Hospital, Tokyo, Japan., Tanaka M; Department of Hematology, Kanagawa Cancer Center, Yokohama, Japan., Ozawa Y; Department of Hematology, Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital, Nagoya, Japan., Ota S; Department of Hematology, Sapporo Hokuyu Hospital, Sapporo, Japan., Kawakita T; Department of Hematology, National Hospital Organisation Kumamoto Medical Center, Kumamoto, Japan., Uchida N; Department of Hematology, Toranomon Hospital, Tokyo, Japan., Sawa M; Department of Hematology and Oncology, Anjo Kosei Hospital, Anjo, Japan., Katayama Y; Department of Hematology, Hiroshima Red Cross Hospital & Atomic-Bomb Survivors Hospital, Hiroshima, Japan., Hiramoto N; Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan., Eto T; Department of Hematology, Hamanomachi Hospital, Fukuoka, Japan., Ichinohe T; Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan., Atsuta Y; Japanese Data Center for Hematopoietic Cell Transplantation, Nagakute, Japan; Department of Registry Science for Transplant and Cellular Therapy, Aichi Medical University School of Medicine, Nagakute, Japan., Kanda J; Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Donor/Source Working Group of the Japanese Society for Transplantation and Cellular Therapy

Journal Article , 2024

Comparison of biosimilar filgrastim and originator filgrastim for peripheral blood stem cell mobilization for allogeneic hematopoietic stem cell transplantation.

Shahzad M; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.; H. Lee Moffitt Cancer Center, Tampa, Florida, USA.; Mikael Rayaan Foundation Global Health Consortium, Kansas City, USA., Amin MK; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.; Mikael Rayaan Foundation Global Health Consortium, Kansas City, USA., Bellman P; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA., Al-Ramahi J; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.; Mikael Rayaan Foundation Global Health Consortium, Kansas City, USA., Noor J; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA., Vyas A; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA., Mahmoudjafari Z; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.; Mikael Rayaan Foundation Global Health Consortium, Kansas City, USA., McGuirk M; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA., DeJarnette S; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.; Mikael Rayaan Foundation Global Health Consortium, Kansas City, USA., Ahmed N; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.; Mikael Rayaan Foundation Global Health Consortium, Kansas City, USA., Abdallah AO; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.; Mikael Rayaan Foundation Global Health Consortium, Kansas City, USA., Shune L; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.; Mikael Rayaan Foundation Global Health Consortium, Kansas City, USA., Singh AK; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.; Mikael Rayaan Foundation Global Health Consortium, Kansas City, USA., McGuirk JP; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.; Mikael Rayaan Foundation Global Health Consortium, Kansas City, USA., Abhyankar S; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.; Mikael Rayaan Foundation Global Health Consortium, Kansas City, USA., Mushtaq MU; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.; Mikael Rayaan Foundation Global Health Consortium, Kansas City, USA.

Journal Article; Comparative Study , 2024

Is an earlier strategy for harvesting peripheral blood stem cells in healthy allogeneic donors feasible?

Yaman S; Department of Hematology and Bone Marrow Transplantation Center, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey. Electronic address: drsametyaman@gmail.com., Bozan E; Department of Hematology and Bone Marrow Transplantation Center, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey., Seçilmiş S; Department of Hematology and Bone Marrow Transplantation Center, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey., Candır BA; Department of Hematology and Bone Marrow Transplantation Center, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey., Kılınç A; Department of Hematology and Bone Marrow Transplantation Center, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey., Başcı S; Department of Hematology and Bone Marrow Transplantation Center, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey., Yiğenoğlu TN; Department of Hematology and Bone Marrow Transplantation Center, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey., Çakar MK; Department of Hematology and Bone Marrow Transplantation Center, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey., Dal MS; Department of Hematology and Bone Marrow Transplantation Center, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey., Altuntaş F; Department of Hematology and Bone Marrow Transplantation Center, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey.

Journal Article , 2024

Autologous peripheral blood stem cell mobilization and apheresis in pediatric patients with cancer: A single-center report of 64 procedures.

Yazal Erdem A; Department of Pediatric Hematology and Oncology, Ankara Bilkent City Hospital, University of Health Sciences Turkey, Ankara, Turkey., Özyörük D; Department of Pediatric Hematology and Oncology, Ankara Bilkent City Hospital, University of Health Sciences Turkey, Ankara, Turkey., Ok Bozkaya İ; Department of Pediatric Hematology and Oncology, Ankara Bilkent City Hospital, University of Health Sciences Turkey, Ankara, Turkey., Çakmakcı S; Department of Pediatric Hematology and Oncology, Ankara Bilkent City Hospital, University of Health Sciences Turkey, Ankara, Turkey., Emir S; Department of Pediatrics, Atılım University Faculty of Medicine, Ankara, Turkey., Demir HA; Department of Pediatric Hematology and Oncology, Memorial Private Hospital, Ankara, Turkey., Özgüner HM; Department of Histology and Embriology, Ankara Yıldırım Beyazıt University, Ankara, Turkey., Ergürhan İlhan İ; Department of Pediatric Hematology and Oncology, Ankara Bilkent City Hospital, University of Health Sciences Turkey, Ankara, Turkey., Özbek NY; Department of Pediatric Hematology and Oncology, Ankara Bilkent City Hospital, University of Health Sciences Turkey, Ankara, Turkey.

Journal Article , 2024

Peripheral blood stem cells mobilization in patients with relapsed or refractory lymphomas: A single-center experience.

Halacoglu A; Department of Hematology, Medicalpark Gaziosmanpasa Hospital, Istinye University Faculty of Medicine, Istanbul, Turkey., Serefhanoglu S

Journal Article , 2024

Autologous peripheral blood stem cell harvest timing by absolute neutrophil count in children and young adult patients: Single-institute experience.

Syu WR; Department of Pediatrics, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan; Department of Pediatrics, Chang Gung Memorial Hospital, Taoyuan, Taiwan., Liu YL; Department of Pediatrics, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan; Department of Pediatrics, Taipei Medical University Hospital, Taipei, Taiwan; Taipei Cancer Center, Taipei Medical University, Taipei, Taiwan., Miser JS; Taipei Cancer Center, Taipei Medical University, Taipei, Taiwan; Department of Pediatrics, City of Hope National Medical Center, Duarte, CA, USA., Kao MH; Laboratory Department, Bionet Corp., Taipei, Taiwan., Chen SH; Department of Pediatrics, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan; Taipei Cancer Center, Taipei Medical University, Taipei, Taiwan; Department of Pediatrics, Shuang Ho Hospital, Ministry of Health and Welfare, Taipei Medical University, New Taipei, Taiwan. Electronic address: 13081@s.tmu.edu.tw.

Journal Article , 2025

Comparison of the efficacy and total cost of peripheral blood stem cell collections in allogeneic donors using either filgrastim (Neupogen®) or filgrastim aafi (Nivestym®).

Su C; Alix School of Medicine - Mayo Clinic Arizona, Scottsdale, AZ, United States., Su LL; Department of Laboratory Medicine and Pathology - Mayo Clinic Hospital, Phoenix, AZ, United States., Gray KL; Department of Laboratory Medicine and Pathology - Mayo Clinic Hospital, Phoenix, AZ, United States., Karlene CE; Department of Laboratory Medicine and Pathology - Mayo Clinic Hospital, Phoenix, AZ, United States., Kinard TN; Department of Laboratory Medicine and Pathology - Mayo Clinic Hospital, Phoenix, AZ, United States., Williams LA 3rd; Department of Laboratory Medicine and Pathology - Mayo Clinic Hospital, Phoenix, AZ, United States. Electronic address: williams.lawrence@mayo.edu.

Journal Article; Comparative Study , 2025

Challenges in Autologous Peripheral Blood Stem Cell Collection in a Patient With IgM Myeloma and Cryoglobulinaemia.

Gillies J; Transfusion Medicine, Scottish National Blood Transfusion Centre, Glasgow, Scotland., Drummond S; Beatson Oncology Centre, Glasgow, Scotland.

Case Reports; Journal Article , 2025

Intra-apheresis Cycling to Improve the Clinical Efficacy of Peripheral Blood Stem Cell Donations.

Wadley AJ; School of Sport, Exercise, and Rehabilitation Sciences, University of Birmingham, Birmingham, B15 2TT, UK. a.j.wadley@bham.ac.uk., Pradana F; School of Sport, Exercise, and Rehabilitation Sciences, University of Birmingham, Birmingham, B15 2TT, UK.; Nutrition Study Program, Tadulako University, Palu, Indonesia., Nijjar T; School of Sport, Exercise, and Rehabilitation Sciences, University of Birmingham, Birmingham, B15 2TT, UK., Drayson MT; Clinical Immunology Service, University of Birmingham, Birmingham, UK., Lucas SJE; School of Sport, Exercise, and Rehabilitation Sciences, University of Birmingham, Birmingham, B15 2TT, UK., Kinsella FAM; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.; Birmingham Centre of Cellular Therapy and Transplantation, Queen Elizabeth Hospital, Birmingham, UK., Cox PA; School of Sport, Exercise, and Rehabilitation Sciences, University of Birmingham, Birmingham, B15 2TT, UK.

Journal Article; Review , 2025

Impact of single dose of pegfilgrastim on peripheral blood stem cell harvest in patients with multiple myeloma or malignant lymphoma.

Goto H; Department of Hematology, Graduate School of Medicine, Hokkaido University Faculty of Medicine, Sapporo, Japan.; Division of Laboratory and Transfusion Medicine, Hokkaido University Hospital, Sapporo, Japan., Sawa M; Department of Hematology and Oncology, Anjo Kosei Hospital, Anjo, Japan., Fujiwara SI; Division of Hematology, Department of Medicine, Jichi Medical University, Shimotsuke, Japan., Ri M; Department of Hematology and Oncology, Graduate School of Medical Sciences, Nagoya City University, Nagoya, Japan., Ishida T; Department of Hematology, Japanese Red Cross Medical Center, Tokyo, Japan., Takeuchi M; Division of Hematology-Oncology, Chiba Cancer Center, Chiba, Japan., Ishitsuka K; Department of Hematology and Rheumatology, Kagoshima University, Kagoshima, Japan., Toyosaki M; Department of Hematology and Oncology, School of Medicine, Tokai University, Isehara, Japan., Sunami K; Department of Hematology, NHO Okayama Medical Center, Okayama, Japan., Tsukada J; Department of Hematology, University of Occupational and Environmental Health, Kitakyushu, Japan., Sonoki T; Department of Hematology/Oncology, Wakayama Medical University, Wakayama, Japan., Shimogomi A; Kyowa Kirin Co., Ltd, Tokyo, Japan., Ichihashi Y; Kyowa Kirin Co., Ltd, Tokyo, Japan., Ouchi Y; Kyowa Kirin Co., Ltd, Tokyo, Japan., Miyamoto T; Department of Hematology, Faculty of Medicine, Institute of Medical Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan., Hino M; Department of Hematology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan., Maeda Y; Department of Hematology and Oncology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan., Teshima T; Department of Hematology, Graduate School of Medicine, Hokkaido University Faculty of Medicine, Sapporo, Japan. teshima@med.hokudai.ac.jp.; Division of Laboratory and Transfusion Medicine, Hokkaido University Hospital, Sapporo, Japan. teshima@med.hokudai.ac.jp.

Clinical Trial, Phase II; Equivalence Trial; Journal Article; Multicenter Study , 2025

Donor selection in T-cell-replete haploidentical donor peripheral blood stem cell transplantation.

Wada F; Department of Hematology, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Iwasaki M; Department of Hematology, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Hirayama M; Department of Pediatrics, Mie University Graduate School of Medicine, Tsu, Japan., Kawamura K; Department of Hematology, Tottori University Hospital, Tottori, Japan., Kaida K; Department of Hematology, Hyogo Medical University Hospital, Nishinomiya, Japan., Doki N; Hematology Division, Tokyo Metropolitan Cancer and Infectious Disease Center, Komagome Hospital, Tokyo, Japan., Nakamae H; Department of Hematology, Osaka Metropolitan University Hospital, Osaka, Japan., Hasegawa Y; Department of Hematology, Hokkaido University Hospital, Sapporo, Japan., Fukuda T; Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan., Eto T; Department of Hematology, Hamanomachi Hospital, Fukuoka, Japan., Hiramoto N; Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan., Maruyama Y; Department of Hematology, University of Tsukuba Hospital, Tsukuba, Japan., Nagafuji K; Division of Hematology and Oncology, Department of Medicine, Kurume University Hospital, Kurume, Japan., Ota S; Department of Hematology, Sapporo Hokuyu Hospital, Sapporo, Japan., Ishikawa J; Department of Hematology, Osaka International Cancer Institute, Osaka, Japan., Ando T; Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga, Japan., Ichinohe T; Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan., Atsuta Y; Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan.; Department of Registry Science for Transplant and Cellular Therapy, Aichi Medical University School of Medicine, Nagakute, Japan., Nakasone H; Division of Emerging Medicine for Integrated Therapeutics (EMIT), Center for Molecular Medicine, Jichi Medical University, Shimotsuke, Japan.; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan., Kanda J; Department of Hematology, Graduate School of Medicine, Kyoto University, Kyoto, Japan. jkanda16@kuhp.kyoto-u.ac.jp.

Journal Article , 2025

Efficiency and safety of granulocyte colony-stimulating factor combined with plerixafor for autologous peripheral blood hematopoietic stem cell mobilization in light chain amyloidosis.

Liu M; National Clinical Research Center for Kidney Diseases, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China., Chen W; National Clinical Research Center for Kidney Diseases, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China., Guo J; National Clinical Research Center for Kidney Diseases, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China., Wu X; National Clinical Research Center for Kidney Diseases, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China., Huang X; National Clinical Research Center for Kidney Diseases, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China. Electronic address: hxhszb@163.com.

Journal Article , 2025

Engraftment outcome of patients with anti-HLA antibodies in HLA-mismatched peripheral blood stem cell transplantation.

Hagino T; Department of Hematology, Tama-Hokubu Medical Center, Tokyo Metropolitan Health and Medical Treatment Corporation, Tokyo, Japan., Ikegame K; Hematopoietic Cell Transplantation Center, Aichi Medical University of School of Medicine, 1-1 Yazakokarimata, Nagakute, Aichi, 480-1195, Japan. kame@aichi-med-u.ac.jp., Tanaka H; HLA Foundation Laboratory, Kyoto, Japan., Kanda Y; Division of Hematology, Saitama Medical Center, Jichi Medical University, Saitama, Japan., Kaida K; Department of Hematology, Hyogo Medical University Hospital, Hyogo, Japan., Fukuda T; Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan., Kondo Y; Department of Hematology, Toyama Prefectural Central Hospital, Toyama, Japan., Sato M; Department of Hematology/Oncology, Osaka Women's and Children's Hospital, Osaka, Japan., Doki N; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan., Nakamae H; Department of Hematology, Osaka Metropolitan University Hospital, Osaka, Japan., Matsuoka KI; Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan.; Department of Hematology, Endocrinology and Metabolism, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan., Mori Y; Hematology, Oncology & Cardiovascular Medicine, Kyushu University Hospital, Fukuoka, Japan., Sano H; Department of Pediatric Oncology, Fukushima Medical University Hospital, Fukushima, Japan., Eto T; Department of Hematology, Hamanomachi Hospital, Fukuoka, Japan., Kawakita T; Department of Hematology, National Hospital Organization Kumamoto Medical Center, Kumamoto, Japan., Hashii Y; Department of Pediatrics, Osaka International Cancer Institute, Osaka, Japan., Ichinohe T; Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan., Atsuta Y; Japanese Data Center for Hematopoietic Cell Transplantation, Aichi, Japan.; Department of Registry Science for Transplant and Cellular Therapy, Aichi Medical University School of Medicine, Aichi, Japan., Kanda J; Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

HLA Working Group of Japanese Society for Transplantation, Cellular Therapy

Journal Article , 2025

Melphalan-based conditioning with post-transplant cyclophosphamide for peripheral blood stem cell transplantation: donor effect.

Koller PB; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA, USA., Othman T; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA, USA., Yang D; Computational and Quantitative Medicine, City of Hope National Medical Center, Duarte, CA, USA., Mokhtari S; Clinical and Translational Project Development, City of Hope National Medical Center, Duarte, CA, USA., Samara Y; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA, USA., Blackmon A; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA, USA., Agrawal V; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA, USA., Pourhassan H; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA, USA., Ball BJ; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA, USA., Amanam I; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA, USA., Arslan S; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA, USA., Otoukesh S; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA, USA., Sandhu KS; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA, USA., Aldoss I; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA, USA., Ali H; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA, USA., Salhotra A; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA, USA., Aribi A; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA, USA., Artz A; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA, USA., Becker PS; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA, USA., Pullarkat V; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA, USA., Stewart FM; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA, USA., Smith EP; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA, USA., Stein A; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA, USA., Marcucci G; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA, USA., Forman SJ; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA, USA., Nakamura R; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA, USA., Al Malki MM; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA, USA. malmalki@coh.org.

Journal Article , 2025

Quality Assessment of Cryopreserved Peripheral Blood Stem Cell Products: Evaluation of Two Methods for Flow Cytometric Viability Testing.

Rimac V; Department of Transfusion Medicine and Transplantation Biology, University Hospital Centre Zagreb, Zagreb, Croatia., Bojanić I; Department of Transfusion Medicine and Transplantation Biology, University Hospital Centre Zagreb, Zagreb, Croatia.; School of Medicine, University of Zagreb, Zagreb, Croatia., Škifić M; Department of Transfusion Medicine and Transplantation Biology, University Hospital Centre Zagreb, Zagreb, Croatia., Dabelić S; Faculty of Pharmacy and Biochemistry, University of Zagreb, Zagreb, Croatia., Golubić Ćepulić B; Department of Transfusion Medicine and Transplantation Biology, University Hospital Centre Zagreb, Zagreb, Croatia.; School of Medicine, University of Zagreb, Zagreb, Croatia.

Journal Article , 2025

Outcomes of Delayed HLA Haploidentical Transplantation with Peripheral Blood Allografts for High-Risk Patients with Severe Aplastic Anemia.

José C JP; Department of Hematology, Internal Medicine Division, Dr. José Eleuterio González University Hospital; and School of Medicine, Universidad Autónoma de Nuevo León, Monterrey, Mexico., Mariana GT; Department of Hematology, Internal Medicine Division, Dr. José Eleuterio González University Hospital; and School of Medicine, Universidad Autónoma de Nuevo León, Monterrey, Mexico., Renata V BL; Department of Hematology, Internal Medicine Division, Dr. José Eleuterio González University Hospital; and School of Medicine, Universidad Autónoma de Nuevo León, Monterrey, Mexico., Olga G CR; Department of Hematology, Internal Medicine Division, Dr. José Eleuterio González University Hospital; and School of Medicine, Universidad Autónoma de Nuevo León, Monterrey, Mexico., César H GA; Department of Hematology, Internal Medicine Division, Dr. José Eleuterio González University Hospital; and School of Medicine, Universidad Autónoma de Nuevo León, Monterrey, Mexico., David GA; Department of Hematology, Internal Medicine Division, Dr. José Eleuterio González University Hospital; and School of Medicine, Universidad Autónoma de Nuevo León, Monterrey, Mexico.

Journal Article , 2025

Outcomes of Peripheral Blood Haploidentical Stem Cell Transplantation With Post-Transplant Cyclophosphamide and Earlier Initiation of Immunosuppression.

Ma'koseh M; Department of Internal Medicine, King Hussein Cancer Center, Amman, Jordan; School of Medicine, The University of Jordan, Amman, Jordan. Electronic address: mm.09744@khcc.jo., Rahman ZA; Department of Internal Medicine, King Hussein Cancer Center, Amman, Jordan; School of Medicine, The University of Jordan, Amman, Jordan., Yaseen A; Department of Internal Medicine, King Hussein Cancer Center, Amman, Jordan., Mesmar A; Department of Internal Medicine, King Hussein Cancer Center, Amman, Jordan., Abu-Jazar H; Department of Internal Medicine, King Hussein Cancer Center, Amman, Jordan., Saadeh S; Department of Internal Medicine, King Hussein Cancer Center, Amman, Jordan; School of Medicine, The University of Jordan, Amman, Jordan., Mufarrej D; Department of Pharmacy, King Hussein Cancer Center, Amman, Jordan., Alfar R; Department of Internal Medicine, King Hussein Cancer Center, Amman, Jordan., Da'na W; Department of Internal Medicine, King Hussein Cancer Center, Amman, Jordan., Halahleh K; Department of Internal Medicine, King Hussein Cancer Center, Amman, Jordan., Hashem H; Department of Pediatric, King Hussein Cancer Center, Amman, Jordan., Al-Ibraheem A; Department of Nuclear Medicine, King Hussein Cancer Center, Amman, Jordan., Al-Rabi K; Department of Internal Medicine, King Hussein Cancer Center, Amman, Jordan; School of Medicine, The University of Jordan, Amman, Jordan., Abdel-Razeq H; Department of Internal Medicine, King Hussein Cancer Center, Amman, Jordan; School of Medicine, The University of Jordan, Amman, Jordan.

Journal Article , 2025

[Clinical efficacy analysis of haploidentical high-dose in vitro non-T-cell-depleted peripheral blood hematopoietic stem cell transplantation for the treatment of adult patients with Ph(+) acute lymphoblastic leukemia].

Xu JL; Hematologic Disease Center, the First Affiliated Hospital of Xinjiang Medical University, Institute of Hematology of Xinjiang Uygur Autonomous Region, Urumqi 830054, China., Du XF; The People's Hospital of Anyang, Anyang 455000, China., Yuan HL; Hematologic Disease Center, the First Affiliated Hospital of Xinjiang Medical University, Institute of Hematology of Xinjiang Uygur Autonomous Region, Urumqi 830054, China., Wang HB; Hematologic Disease Center, the First Affiliated Hospital of Xinjiang Medical University, Institute of Hematology of Xinjiang Uygur Autonomous Region, Urumqi 830054, China., Chen G; Hematologic Disease Center, the First Affiliated Hospital of Xinjiang Medical University, Institute of Hematology of Xinjiang Uygur Autonomous Region, Urumqi 830054, China., Yang RX; Hematologic Disease Center, the First Affiliated Hospital of Xinjiang Medical University, Institute of Hematology of Xinjiang Uygur Autonomous Region, Urumqi 830054, China., Zhang KL; Hematologic Disease Center, the First Affiliated Hospital of Xinjiang Medical University, Institute of Hematology of Xinjiang Uygur Autonomous Region, Urumqi 830054, China., Gulibadanmu A; Hematologic Disease Center, the First Affiliated Hospital of Xinjiang Medical University, Institute of Hematology of Xinjiang Uygur Autonomous Region, Urumqi 830054, China., Qu JH; Hematologic Disease Center, the First Affiliated Hospital of Xinjiang Medical University, Institute of Hematology of Xinjiang Uygur Autonomous Region, Urumqi 830054, China., Jiang M; Hematologic Disease Center, the First Affiliated Hospital of Xinjiang Medical University, Institute of Hematology of Xinjiang Uygur Autonomous Region, Urumqi 830054, China.

English Abstract; Journal Article , 2025

Improved survival in older patients with myeloid malignancies undergoing haploidentical peripheral blood stem cell transplantation with low-dose anti-thymocyte globin (ATG)/post-cyclophosphamide (PTCy)-based regimen for graft-versus-host disease prophylaxis.

Jia Y; Department of Hematology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China., Xia X; Department of Hematology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China., Yang J; Department of Hematology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China., Cai Y; Department of Hematology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China., Tong Y; Department of Hematology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China., Qiu H; Department of Hematology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China., Huang C; Department of Hematology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China., Zhou K; Department of Hematology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China., Zhang Y; Department of Hematology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China., Shen C; Department of Hematology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China., Wan L; Department of Hematology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China., Song X; Department of Hematology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. shongxm@sjtu.edu.cn.

Journal Article , 2025